Hornicka nemocnice s poliklinikou spol. s r.o.

At Hornicka nemocnice s poliklinikou spol. s r.o., the clinical trial portfolio is focused on cardiovascular diseases, with studies centered on conditions such as atherosclerotic cardiovascular disease, established cardiovascular disease, high cardiovascular risk, and hypertension. The research is aimed at finding better ways to lower the risk of serious heart and vascular events and improve long-term outcomes for patients.

• Evaluating new treatment approaches for hypertension that is not adequately controlled
• Studying therapies for people with established cardiovascular disease or elevated cardiovascular risk
• Assessing whether treatment can reduce major events such as heart attack, stroke, and heart failure
• Investigating options for patients with elevated lipoprotein(a) and related cardiovascular risk

This work includes trials designed to test whether new therapies can prevent major cardiovascular complications and improve protection for people living with persistent risk factors.

The Interni ambulance department is involved in research that looks beyond symptom control and focuses on preventing serious outcomes in cardiovascular disease. These studies aim to determine whether emerging treatments can reduce the likelihood of events such as coronary heart disease death, myocardial infarction, and urgent revascularization procedures.

• Testing whether new therapies can lower the chance of cardiovascular death and nonfatal complications
• Comparing treatment effects in patients with ASCVD and elevated lipoprotein(a)
• Supporting research into better prevention strategies for people at high cardiovascular risk

The studies at this site reflect a strong interest in improving both prevention and treatment effectiveness for patients facing ongoing cardiovascular threats.